News From the American Society of Hematology (ASH) 2018 Annual Meeting

Look for new and expanded programs added day by day.

 

 

AML

ASH 2018 AML Treatment and Research Updates From an Expert Roundtable

Patient Power founders Andrew and Esther Schorr are joined by a panel of AML experts to discuss highlights from the 2018 American Society of Hematology (ASH) annual meeting in what they call an “AML treatment revolution.” Tune in to find out the latest news.

Published:

Hodgkin Lymphoma

Hodgkin Lymphoma News From ASH 2018: Updates From Leading Experts

As part of Patient Power’s coverage from the 2018 American Society of Hematology (ASH) annual meeting, a panel of experts in Hodgkin lymphoma , including Dr. Andrew Evens, Dr. Joshua Brody, as well as Andrew Schorr, gathered to discuss the latest news and developments related to research and treatment of Hodgkin lymphoma.

Published:

CLL

CLL ASH News 2018: Staying Informed About Clinical Trials

At the 2018 American Society of Hematology (ASH) conference in San Diego, Patient Power host and CLL patient advocate, Lee Swanson, interviews Dr. Adrian Wiestner, Senior Investigator, Laboratory of Lymphoid Malignancies at the National Heart, Lung, and Blood Institute (NHLBI).

Published:

A CLL Expert Roundtable: Treatment News From ASH 2018

On-site in San Diego, CA at the 2018 American Society of Hematology (ASH) annual meeting, a panel of CLL experts joined Patient Power to share breakthroughs in treatment research announced at the conference and explore emerging approaches to therapy. Watch now to find out the latest CLL news.

Published:

ASH 2018 Daily Wrap: CLL News

On location in San Diego, CA, Patient Power founders Andrew and Esther Schorr are joined by a panel of experts to discuss research developments announced at ASH 2018. Watch day three of Patient Power’s daily wrap to hear the latest blood cancer-related treatment news.

Published:

Mantle Cell Lymphoma

An Evolving Treatment Landscape: Mantle Cell Lymphoma Treatment and Research News From an Expert

Noted expert Dr. Stephen Douglas Smith joined Patient Power to share promising advances being made in therapies for mantle cell lymphoma. Watch now to stay up-to-date with the latest treatment and research news.

Published:

MPNs

Updates From ASH 2018: The Latest on Interferon Therapy in MPNs

MPN experts, Dr. Srdan Verstovsek and Dr. Abdulraheem Yacoub provide an update from ASH 2018, including the latest in interferon research for the treatment of polycythemia vera (PV).

Published:

MPN News From ASH 2018: Perspectives From Leading Experts

As part of Patient Power’s coverage from the 2018 American Society of Hematology (ASH) annual meeting, a panel of experts in myeloproliferative neoplasms (MPNs), including Dr. Srdan Verstovsek, Dr. Abdulraheem Yacoub and Lindsey Lyle, as well as Andrew Schorr, gathered to discuss the latest news and developments related to research and treatment of MPNs.

Published:

ASH 2018 Daily Wrap: MPN News

On location in San Diego, CA, Patient Power founders Andrew and Esther Schorr are joined by a panel of experts to discuss research developments announced at ASH 2018. Watch day one of Patient Power’s daily wrap to hear the latest blood cancer-related treatment news.

Published:

Myeloma

ASH 2018 Daily Wrap: Myeloma News

In day two of Patient Power’s daily wrap-up from the 2018 American Society of Hematology (ASH) meeting in San Diego, Patient Power founders Andrew and Esther Schorr are joined by a panel of leading experts to discuss impressive treatment advances and important headlines in clinical research. Watch now to find out the latest news in cancer care.

Published:

Non-Hodgkin Lymphoma

Updates From ASH 2018 Peripheral T-Cell Lymphoma With Dr. Horwitz

Dr. Steven Horwitz joins Lee Swanson to discuss new approvals and advancements made in peripheral T-cell lymphoma at ASH 2018. Dr. Steven Horwitz has been instrumental in these studies leading to approval for new treatments.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on December 11, 2018